During follow-up, both the nine patients with longitudinal data and the entire cohort showed a decreasing trend in the proportion of LTB+ Th17 cells at F1.
← all excerpts
T cell-driven sustained inflammation and immune dysregulation mimicking immunosenescence for up to three years post-COVID-19.
1
—
—